712 North ^Company

712 North is a pre-clinical stage pharmaceutical company based in California. They develop modulators of the dynamic mitochondrial network for a range of age-related diseases such as Alzheimer's, cancer, glaucoma, and cardiovascular disease. The mechanism of action ties the biology also to a rare pediatric indication with unmet medical need. 712 North can leverage this orphan disease as fast to market strategy. The main goal is to become the global leader in innovative personalized mitochondrial medicines.